John Yarnold
About
John Yarnold is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Oncology.
According to data from OpenAlex, John Yarnold has authored 193 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Cancer Research, 77 papers in Radiology, Nuclear Medicine and Imaging and 73 papers in Oncology. Recurrent topics in John Yarnold's work include Breast Cancer Treatment Studies (106 papers), Advanced Radiotherapy Techniques (52 papers) and Effects of Radiation Exposure (34 papers). John Yarnold is often cited by papers focused on Breast Cancer Treatment Studies (106 papers), Advanced Radiotherapy Techniques (52 papers) and Effects of Radiation Exposure (34 papers). John Yarnold collaborates with scholars based in United Kingdom, United States and Germany. John Yarnold's co-authors include Joanne Haviland, Judith M. Bliss, Marie‐Catherine Vozenin, Philip Evans, Ellen M. Donovan, John R. Owen, Søren M. Bentzen, Peter Hoskin, Anna M. Kirby and J. Regan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
In The Last Decade
John Yarnold
187 papers receiving 10.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| John Yarnold United Kingdom | 50 | 5.2k | 3.6k | 3.5k | 3.3k | 2.9k | 193 | 10.4k | ||
| Marie Overgaard Denmark | 55 | 7.3k 1.4× | 2.0k 0.5× | 2.5k 0.7× | 4.3k 1.3× | 2.6k 0.9× | 139 | 12.5k | ||
| Alphonse G. Taghian United States | 59 | 7.0k 1.3× | 2.1k 0.6× | 2.0k 0.6× | 5.2k 1.6× | 1.8k 0.6× | 268 | 11.7k | ||
| Gary M. Freedman United States | 44 | 4.1k 0.8× | 1.5k 0.4× | 1.7k 0.5× | 2.5k 0.7× | 1.9k 0.7× | 195 | 7.4k | ||
| Ivo A. Olivotto Canada | 60 | 8.9k 1.7× | 2.2k 0.6× | 2.0k 0.6× | 5.8k 1.7× | 1.9k 0.6× | 242 | 13.9k | ||
| Geertjan van Tienhoven Netherlands | 45 | 2.5k 0.5× | 1.6k 0.5× | 1.4k 0.4× | 3.4k 1.0× | 3.9k 1.3× | 204 | 8.9k | ||
| Carolyn Taylor United Kingdom | 15 | 4.1k 0.8× | 2.2k 0.6× | 2.3k 0.7× | 2.2k 0.7× | 1.8k 0.6× | 22 | 7.2k | ||
| Samuel Hellmän United States | 57 | 3.8k 0.7× | 1.1k 0.3× | 1.7k 0.5× | 3.8k 1.1× | 3.0k 1.0× | 238 | 10.8k | ||
| Abram Recht United States | 65 | 10.1k 1.9× | 1.4k 0.4× | 1.6k 0.5× | 6.1k 1.8× | 2.2k 0.8× | 237 | 14.6k | ||
| Walter Van den Bogaert Belgium | 41 | 2.1k 0.4× | 1.9k 0.5× | 1.9k 0.6× | 1.8k 0.5× | 2.4k 0.8× | 78 | 6.8k | ||
| Melvin Deutsch United States | 43 | 9.3k 1.8× | 1.4k 0.4× | 1.7k 0.5× | 5.8k 1.7× | 2.1k 0.7× | 161 | 15.6k |
Countries citing papers authored by John Yarnold
Since
Specialization
Citations
This map shows the geographic impact of John Yarnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Yarnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Yarnold more than expected).
Fields of papers citing papers by John Yarnold
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by John Yarnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Yarnold. The network helps show where John Yarnold may publish in the future.
Co-authorship network of co-authors of John Yarnold
This figure shows the co-authorship network connecting the top 25 collaborators of John Yarnold. A scholar is included among the top collaborators of John Yarnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Yarnold. John Yarnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kirby, Anna M., Laura Finneran, Clare Griffin, et al.. (2025). Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial. The Lancet Oncology. 26(7). 898–910.
2.
Lightowlers, Sara, Elena Provenzano, Judith M. Bliss, et al.. (2024). Abstract PO5-22-04: Genomic analysis of local recurrences following risk adapted breast radiotherapy in the IMPORT trials defines 'true recurrences' and 'new primaries'. Cancer Research. 84(9_Supplement). PO5–22.
3.
Kirby, Anna M., Clare Griffin, Laura Finneran, et al.. (2023). Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003). International Journal of Radiation Oncology*Biology*Physics. 117(4). e7–e7.
4.
Haviland, Joanne, Mariella Mannino, Clare Griffin, et al.. (2017). Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials. Radiotherapy and Oncology. 126(1). 155–162.
5.
Brunt, Adrian Murray, Duncan Wheatley, John Yarnold, et al.. (2016). Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiotherapy and Oncology. 120(1). 114–118.
6.
Somaiah, Navita, Melvin L.K. Chua, Lone Gothard, et al.. (2016). Correlation between the radiation responses of fibroblasts cultured from individual patients and the risk of late reaction after breast radiotherapy. Cancer Letters. 374(2). 324–330.
7.
Dorling, Leila, Gillian C. Barnett, Kyriaki Michailidou, et al.. (2015). Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity. Clinical Cancer Research. 22(6). 1413–1420.
8.
Somaiah, Navita, Kai Rothkamm, & John Yarnold. (2015). Where Do We Look for Markers of Radiotherapy Fraction Size Sensitivity?. Clinical Oncology. 27(10). 570–578.
9.
Tsang, Y., L. Ciurlionis, Cliona Kirwan, et al.. (2015). IMPORT Trial Management Group. Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.. British Journal of Radiology. 88(1056). 1–8.
10.
Bartlett, Frederick R., R. Colgan, Ellen M. Donovan, et al.. (2014). Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy. Journal of Visualized Experiments.
11.
Bartlett, Frederick R., R. Colgan, Ellen M. Donovan, et al.. (2014). Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy. Journal of Visualized Experiments.
12.
Haviland, Joanne, John R. Owen, John Dewar, et al.. (2013). The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. The Lancet Oncology. 14(11). 1086–1094.
13.
Somaiah, Navita, John Yarnold, Frances Daley, et al.. (2012). The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy. Clinical Cancer Research. 18(19). 5479–5488.
14.
Venables, Karen, Y. Tsang, L. Ciurlionis, Charlotte E. Coles, & John Yarnold. (2012). Does Participation in Clinical Trials Influence the Implementation of New Techniques? A Look at Changing Techniques in Breast Radiotherapy in the UK. Clinical Oncology. 24(8). e100–e105.
15.
Yarnold, John & Marie‐Catherine Vozenin. (2010). Pathogenetic mechanisms in radiation fibrosis. Radiotherapy and Oncology. 97(1). 149–161.
16.
Martin, Susan, Debasis Bagchi, Judith Earl, et al.. (2006). Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration. Radiotherapy and Oncology. 79(1). 45–51.
17.
Gothard, Lone, A.W.B. Stanton, David Lawrence, et al.. (2003). Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiotherapy and Oncology. 70(3). 217–224.
18.
Yarnold, John, et al.. (1996). Molecular biology for clinical oncologists (2nd ed.). Lancaster EPrints (Lancaster University).
19.
Moody, A.M., W. P. M. Mayles, Judith M. Bliss, et al.. (1995). The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Medical dosimetry. 20(1). 68–68.
20.
Price, P., et al.. (1986). Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiotherapy and Oncology. 6(4). 247–255.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marie Overgaard Breakdown of academic impact, for papers by Alphonse G. Taghian Breakdown of academic impact, for papers by Gary M. Freedman Breakdown of academic impact, for papers by Ivo A. Olivotto Breakdown of academic impact, for papers by Geertjan van Tienhoven Breakdown of academic impact, for papers by Carolyn Taylor Breakdown of academic impact, for papers by Samuel Hellmän Breakdown of academic impact, for papers by Abram Recht Breakdown of academic impact, for papers by Walter Van den Bogaert Breakdown of academic impact, for papers by Melvin Deutsch